Serum hepatitis <scp>B</scp> surface antigen quantification as a useful assessment for significant fibrosis in hepatitis <scp>B</scp> e antigen‐positive hepatitis <scp>B</scp> virus carriers

Abstract

Serum qHBsAg-based simple tests, especially GqHBsR, can accurately and specifically identify significant fibrosis in treatment-naïve HBeAg-positive HBV carriers.